1512 ET - Chemours, the producer of fluorine-based refrigerants, specialty plastics and titanium dioxide pigments, is entering a more favorable environment, according to Mizuho in a research report. Analysts say one major tailwind is that industry stockpiling of the banned refrigerant Freon is normalizing amid the larger shift to next-gen refrigerants, of which Chemours is one of only two producers. The analysts also say that litigation surrounding PFAS, also known as forever chemicals, seems to be moving in the right direction. They believe a potential settlement in advance of the New Jersey PFAS trial, anticipated in spring/summer, would likely help limit the scope of Chemours' potential liability. Mizuho upgrades Chemours to outperform from neutral. Chemours is up 2.6% to $14.19. (sarina.isaacs@wsj.com)
(END) Dow Jones Newswires
March 27, 2025 15:14 ET (19:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。